Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Cardiovascular DiabetologyOpen Access

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRasmus StenlidSASami El AmraniSCSara Y. Cerenius

Discussion

Loading...

Member takes

Overview

This observational analysis finds fasting insulin better detects cardiometabolic risk in children than BMI, suggesting its inclusion may enhance risk assessment.

Key Points

  • Fasting insulin is a superior marker for detecting cardiometabolic risk factors in obese children compared to BMI-SDS.
  • Increased fasting insulin quartiles correlated significantly with dyslipidemia, dysglycemia, and hypertension risk.
  • The study involved 712 participants with obesity and 99 lean controls aged 3 to 18 years, enhancing population diversity.
  • Incorporating fasting insulin into clinical evaluations may prioritize those needing further cardiometabolic health assessments.

Cite This Study

Stenlid et al. (2025) studied this question.

synapsesocial.com/papers/68c24236b210217d647a2caehttps://doi.org/10.1186/s12933-025-02882-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association Between Novel Inflammatory Indices and Metabolic Syndrome in Children and Adolescents with Obesity2025
  2. 2Assessment of Insulin Resistance and Body Composition in Children with Overweight and Obesity: A Pilot Study Using Bioimpedance and Principal Component Analysis2025
  3. 3Assessment of Insulin Resistance and Body Composition in Children With Overweight and Obesity: A Pilot Study Using Bioimpedance and Principal Component Analysis2025
  4. 4Obesity is Associated with Increased Cardiovascular Risk and Increased Prevalence of Insulin Resistance among Apparently Healthy Young Adults2025
  5. 520/ (fasting C-peptide × fasting plasma glucose) as a novel marker for insulin resistance in obese children and adolescents2026